Victor R. Coria-Jiménez Coria-Jiménez

Dr. Victor R. Coria-Jiménez Coria-Jiménez


Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 January 2024 in Annals of Medicine
Verified
Journal Article
Open access
JSJuan Carlos Gutiérrez Santana
Juan Carlos Gutiérrez Santana
VCVictor R. Coria-Jiménez Coria-Jiménez
Victor R. Coria-Jiménez Coria-Jiménez
Burkholderia cepacia complex (Bcc) is a bacterial group with 'natural' multi-antimicrobial resistance. This complex has generated epidemic outbreaks across the world. In people with cystic fibrosis (CF), Bcc can cause severe lung infections that lead to accelerated lung damage, which can be complicated by necrotizing pneumonia accompanied by high fevers, leucocytosis, and bacteraemia, which commonly causes fatal outcomes. Specifically, infection by Burkholderia cenocepacia is considered an exclusion criterion for lung transplantation. The species of Bcc exhibit both genetic and phenotypic hypervariability that complicate their accurate microbiological identification. Automated methods such as MALDI-TOF can err in the determination of species. Their slow growth even in selective agars and the absence of international consensuses on the optimal conditions for their isolation make early diagnosis a difficult challenge to overcome. The absence of correlations between antibiograms and clinical results has resulted in the absence of standardized cut-off values of antimicrobial susceptibility, a fact that brings a latent risk since incorrect antibiotic therapy can induce the selection of more aggressive variants that worsen the clinical picture of the host, added to the absence of a clear therapeutic guide for the eradication of pulmonary infections by Bcc in patients with CF, resulting in frequently ineffective treatments. There is an urgent need to standardize methods and diagnostic tools that would allow an early and accurate diagnosis, as well as to perform clinical studies of the effectiveness of available antibiotics to eradicate Bcc infections, which would allow us to establish standardized therapeutic schemes for Bcc-infected patients.

1 January 2004 in Archives of Medical Research
Verified
Journal Article
Closed access
JEJosé Antonio Enciso-Moreno
José Antonio Enciso-Moreno
NPNorma Pernas-Buitrón
Norma Pernas-Buitrón
MOMaribel Ortiz-Herrera
Maribel Ortiz-Herrera
VCVictor R. Coria-Jiménez Coria-Jiménez
Victor R. Coria-Jiménez Coria-Jiménez

8 October 2022 in Current Microbiology
Verified
Journal Article
Closed access
PDF file
JSJuan Carlos Gutiérrez Santana
Juan Carlos Gutiérrez Santana
AGArmando Gerónimo-Gallegos
Armando Gerónimo-Gallegos
MMMónica B. Martínez-Corona
Mónica B. Martínez-Corona
MLMarisol López-López
Marisol López-López
JTJulia Dolores Toscano-Garibay
Julia Dolores Toscano-Garibay
VCVictor R. Coria-Jiménez Coria-Jiménez
Victor R. Coria-Jiménez Coria-Jiménez

28 June 2008 in Pediatric Cardiology
Verified
Journal Article
Closed access
PDF file
HOHugo Juárez Olguín
Hugo Juárez Olguín
CPCarmen Flores Pérez
Carmen Flores Pérez
BMBlanca Ramírez Mendiola
Blanca Ramírez Mendiola
VCVictor R. Coria-Jiménez Coria-Jiménez
Victor R. Coria-Jiménez Coria-Jiménez
EREunice Sandoval Ramírez
Eunice Sandoval Ramírez
JPJanett Flores Pérez
Janett Flores Pérez


1 January 1998 in Research in Microbiology
Verified
Journal Article
Closed access
VCVictor R. Coria-Jiménez Coria-Jiménez
Victor R. Coria-Jiménez Coria-Jiménez
JRJ. Romero-Olvera
J. Romero-Olvera
CCC. Celis-Cruz
C. Celis-Cruz